Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Oliver Ambrée is active.

Publication


Featured researches published by Oliver Ambrée.


Experimental Neurology | 2009

Environmental enrichment enhances cellular plasticity in transgenic mice with Alzheimer-like pathology

Arne Herring; Oliver Ambrée; Manuel Tomm; Henrik Habermann; Norbert Sachser; Werner Paulus; Kathy Keyvani

Alzheimers disease (AD) is accompanied by hippocampal neuronal loss and abnormal neurogenesis, both of which probably contributing to AD-related cognitive deficits. Mounting evidence indicates that cognitive and physical stimulation provided by environmental enrichment improves neurogenesis in healthy animals and counteracts beta-amyloid pathology in mouse models of AD. Here, we hypothesized that environmental enrichment has also an impact on hippocampal neurogenesis in mice with AD-like pathology. Therefore, TgCRND8 mice and wild type littermates were either housed under standard conditions or in an enriched environment for 4 months. Standard housed TgCRND8 mice revealed diminished hippocampal cell proliferation and reduced number of mature newborn neurons compared to wild type littermates under the same housing condition. However, environmental enrichment reversed this genotype effect. Here, we show that cognitive and physical stimulation is capable of increasing the number of newborn mature hippocampal neurons in transgenic mice to wild type levels. Moreover, the expression of various plasticity associated molecules was enhanced in transgenic mice due to enriched housing. This study identifies that environmental enrichment improves diminished cellular plasticity in AD brain, probably enhancing the brain capacity to better compensate for neurodegeneration.


Behavioural Brain Research | 2008

Effects of environmental enrichment on exploration, anxiety, and memory in female TgCRND8 Alzheimer mice

Nicole Görtz; Lars Lewejohann; Manuel Tomm; Oliver Ambrée; Kathy Keyvani; Werner Paulus; Norbert Sachser

After we could recently demonstrate a beneficial effect of environmental enrichment on AD-like brain pathology in female TgCRND8 mice [Ambrée O, Leimer U, Herring A, Görtz N, Sachser N, Heneka MT, et al. Reduction of amyloid angiopathy and Abeta plaque burden after enriched housing in TgCRND8 mice: involvement of multiple pathways. Am J Pathol 2006;169:544-52] the present study focuses on the behavioural effects of environmental enrichment with special emphasis on learning and memory performance in this AD model. In the first experiment spontaneous exploration, locomotor activity and anxiety-related behaviour were assessed as the performance in learning tasks can be biased substantially by exploratory behavioural traits. In the second experiment spatial memory in the Barnes maze test and object recognition memory were examined. Regarding exploratory behaviour transgenic mice from standard housing condition were statistically indistinguishable from wild-type controls. Enrichment had comparable effects in both genotypes indicated by higher levels of exploration and locomotor activity. In transgenic mice the elevated plus-maze revealed less anxiety-related behaviour due to enrichment in contrast to wild-type mice that statistically did not differ in anxiety-related behaviour. Concerning learning and memory performance, cognitive deficits of standard housed transgenic mice could be demonstrated in both learning tasks. Surprisingly, in both housing conditions a significantly higher number of transgenic mice refused to explore any objects compared to wild-type mice. Furthermore, the Barnes maze test revealed deficits of the transgenic mice in spatial memory compared to wild-type mice whereas no effect of environmental enrichment was detectable. Thus environmental enrichment increased exploratory behaviour and decreased anxiety-related behaviour but could not clearly ameliorate deficits in learning and memory performance of TgCRND8 mice.


Behavioural Brain Research | 2008

Wheel-running in a transgenic mouse model of Alzheimer's disease: Protection or symptom?

Helene Richter; Oliver Ambrée; Lars Lewejohann; Arne Herring; Kathy Keyvani; Werner Paulus; Rupert Palme; Chadi Touma; Wolf-Rüdiger Schäbitz; Norbert Sachser

Several studies on both humans and animals reveal benefits of physical exercise on brain function and health. A previous study on TgCRND8 mice, a transgenic model of Alzheimers disease, reported beneficial effects of premorbid onset of long-term access to a running wheel on spatial learning and plaque deposition. Our study investigated the effects of access to a running wheel after the onset of Abeta pathology on behavioural, endocrinological, and neuropathological parameters. From day 80 of age, the time when Abeta deposition becomes apparent, TgCRND8 and wildtype mice were kept with or without running wheel. Home cage behaviour was analysed and cognitive abilities regarding object recognition memory and spatial learning in the Barnes maze were assessed. Our results show that, in comparison to Wt mice, Tg mice were characterised by impaired object recognition memory and spatial learning, increased glucocorticoid levels, hyperactivity in the home cage and high levels of stereotypic behaviour. Access to a running wheel had no effects on cognitive or neuropathological parameters, but reduced the amount of stereotypic behaviour in transgenics significantly. Furthermore, wheel-running was inversely correlated with stereotypic behaviour, suggesting that wheel-running may have stereotypic qualities. In addition, wheel-running positively correlated with plaque burden. Thus, in a phase when plaques are already present in the brain, it may be symptomatic of brain pathology, rather than protective. Whether or not access to a running wheel has beneficial effects on Alzheimer-like pathology and symptoms may therefore strongly depend on the exact time when the wheel is provided during development of the disease.


The International Journal of Neuropsychopharmacology | 2012

Monoamine oxidase A gene DNA hypomethylation - a risk factor for panic disorder?

Katharina Domschke; Nicola Tidow; Henriette Kuithan; Kathrin Schwarte; Benedikt Klauke; Oliver Ambrée; Andreas Reif; Hartmut Schmidt; Volker Arolt; Anette Kersting; Peter Zwanzger; J. Deckert

The monoamine oxidase A (MAOA) gene has been suggested as a prime candidate in the pathogenesis of panic disorder. In the present study, DNA methylation patterns in the MAOA regulatory and exon 1/intron 1 region were investigated for association with panic disorder with particular attention to possible effects of gender and environmental factors. Sixty-five patients with panic disorder (44 females, 21 males) and 65 healthy controls were analysed for DNA methylation status at 42 MAOA CpG sites via direct sequencing of sodium bisulfate treated DNA extracted from blood cells. The occurrence of recent positive and negative life events was ascertained. Male subjects showed no or only very minor methylation with some evidence for relative hypomethylation at one CpG site in intron 1 in patients compared to controls. Female patients exhibited significantly lower methylation than healthy controls at 10 MAOA CpG sites in the promoter as well as in exon/intron 1, with significance surviving correction for multiple testing at four CpG sites (p≤0.001). Furthermore, in female subjects the occurrence of negative life events was associated with relatively decreased methylation, while positive life events were associated with increased methylation. The present pilot data suggest a potential role of MAOA gene hypomethylation in the pathogenesis of panic disorder particularly in female patients, possibly mediating a detrimental influence of negative life events. Future studies are warranted to replicate the present finding in independent samples, preferably in a longitudinal design.


Brain Pathology | 2008

Environmental Enrichment Counteracts Alzheimer’s Neurovascular Dysfunction in TgCRND8 Mice

Arne Herring; Hamzah Yasin; Oliver Ambrée; Norbert Sachser; Werner Paulus; Kathy Keyvani

We and others have recently demonstrated that cognitive and physical stimulation in form of environmental enrichment reduces cerebral β‐amyloid (Aβ) deposition in transgenic mouse models of Alzheimer’s disease. This effect was independent from amyloid precursor protein (APP) expression or processing and rather a consequence of enhanced clearance of Aβ. However, the detailed mechanisms remain unclear. In the present study, we show that environmental enrichment in TgCRND8 mice (carrying human APPSwedish+Indiana) affect the neurovascular unit by increased angiogenesis and differential regulation of Aβ receptor/transporter molecules, namely up‐regulation of LRP1, ApoE and A2M as well as down‐regulation of RAGE so that brain to blood Aβ clearance is facilitated. These results suggest a hitherto unknown effect of environmental enrichment counteracting the vascular dysfunction in Alzheimer diseased brain.


Neurobiology of Aging | 2004

Age- and sex-dependent development of adrenocortical hyperactivity in a transgenic mouse model of Alzheimer's disease.

Chadi Touma; Oliver Ambrée; Nicole Görtz; Kathy Keyvani; Lars Lewejohann; Rupert Palme; Werner Paulus; Katja Schwarze-Eicker; Norbert Sachser

In this study, we investigated mice of the TgCRND8 line, an APP transgenic mouse model of Alzheimers disease (AD), with respect to behavioral, endocrinological, and neuropathological parameters. Our results show that transgenic and wild-type mice did not differ in their general health status, exploratory and anxiety related behavior as well as in the activity of their sympathetic-adrenomedullary system. Significant differences, however, were found regarding body weight, amyloid plaque formation, and the activity of the hypothalamic-pituitary-adrenocortical (HPA) axis. Continuous monitoring of glucocorticoid (GC) concentrations over a period of 120 days, utilizing a noninvasive technique to measure corticosterone metabolites in fecal samples, revealed that transgenic animals showed adrenocortical hyperactivity, starting very early in males (from day 30) and later in females (around day 90). It is hypothesized that these changes in the activity of the HPA axis are linked to amyloid-beta associated pathological alterations in the hippocampus, causing degenerations in the negative feedback regulation of the HPA axis leading to hypersecretion of GC. Thus, the development of adrenocortical hyperactivity might be a key-element in the understanding of AD.


Brain Pathology | 2010

Reduction of Cerebral Oxidative Stress Following Environmental Enrichment in Mice with Alzheimer-Like Pathology

Arne Herring; Mareike Blome; Oliver Ambrée; Norbert Sachser; Werner Paulus; Kathy Keyvani

Oxidative stress is a key feature during progression of chronic neurodegenerative conditions such as Alzheimers disease. In aging humans and animals, voluntary exercise lowers oxidative stress reactions. Additionally, recent work in our lab demonstrated that cognitive and physical stimulation (termed environmental enrichment) counteracts amyloid beta pathology, neurovascular dysfunction and behavioral symptoms in mice with Alzheimer‐like disease. Based on these facts, we hypothesized that cognitive and physical activity can also protect against oxidative stress in Alzheimer‐diseased brain. We, therefore, kept female TgCRND8 mice under standard and enriched housing from day 30 until 5 months of age. Environmental stimulation attenuated pro‐oxidative processes and triggered anti‐oxidative defense mechanisms as indicated by diminished biomarkers for reactive oxygen and nitrogen species, downregulation of pro‐inflammatory and pro‐oxidative mediators, decreased expression of pro‐apoptotic caspases, and upregulation of SOD1 and SOD2. This study identifies a thus far undescribed antagonizing effect of environmental stimulation on Alzheimers disease‐related oxidative damage.


Neurobiology of Aging | 2009

Levodopa ameliorates learning and memory deficits in a murine model of Alzheimer's disease

Oliver Ambrée; Helene Richter; Norbert Sachser; Lars Lewejohann; Ekrem Dere; Maria A. de Souza Silva; Arne Herring; Kathy Keyvani; Werner Paulus; Wolf-Rüdiger Schäbitz

Dopamine plays an important role in learning and memory processes. A deficit of this neurotransmitter as it is apparent in Alzheimers disease (AD) may contribute to cognitive decline, a major symptom of AD patients. The aim of this study was to elucidate whether or not stimulation of the dopaminergic system leads to an improvement of cognitive function and reduction of non-cognitive behavioral alterations in a murine model of AD. Transgenic and wild type male mice of the TgCRND8 line were treated either with the dopamine precursor levodopa or vehicle and tested in two learning tasks, the object-recognition task and the Barnes maze test. Additionally 24 h spontaneous behavior in the home cage was analyzed. In both memory tasks wild type mice performed significantly better than transgenics. However, transgenics treated with levodopa showed a significant object recognition memory and improved acquisition of spatial memory in the Barnes maze compared to vehicle treated transgenics. Concerning spontaneous behavior transgenic mice performed much more stereotypies than wild types. However, there was a trend for reduced stereotypies in the levodopa group in the time the drug was active. Neurochemical analysis revealed elevated levels of dopamine in the neostriata and frontal cortices and reduced levels in the hippocampi of transgenic mice compared to wild types. Thus cognitive deficits and stereotypies may be due to changes in the dopaminergic system as they could be ameliorated by levodopa treatment, that might also have a therapeutic significance for AD.


Human Brain Mapping | 2014

Serotonin transporter gene methylation is associated with hippocampal gray matter volume

Udo Dannlowski; Harald Kugel; Ronny Redlich; Adriane Halik; Ilona Schneider; Nils Opel; Dominik Grotegerd; Kathrin Schwarte; Christiane Schettler; Oliver Ambrée; Stephan Rust; Katharina Domschke; Volker Arolt; Walter Heindel; Bernhard T. Baune; Thomas Suslow; Weiqi Zhang; Christa Hohoff

The serotonin transporter (5‐HTT) and the 5‐HTTLPR/rs25531 polymorphisms in its gene (SLC6A4) have been associated with depression, increased stress‐response, and brain structural alterations such as reduced hippocampal volumes. Recently, epigenetic processes including SLC6A4 promoter methylation were shown to be affected by stress, trauma, or maltreatment and are regarded to be involved in the etiology of affective disorders. However, neurobiological correlates of SLC6A4 promoter methylation have never been studied or compared to genotype effects by means of human neuroimaging hitherto


Bipolar Disorders | 2015

Monocyte activation, brain-derived neurotrophic factor (BDNF), and S100B in bipolar offspring : a follow-up study from adolescence into adulthood

E. Mesman; Manon Hillegers; Oliver Ambrée; Volker Arolt; Willem A. Nolen; Hemmo A. Drexhage

There is increasing evidence that both immune and neurochemical alterations are involved in the pathogenesis of bipolar disorder; however, their precise role remains unclear. In this study, we aimed to evaluate neuro‐immune changes in a prospective study on children of patients with bipolar disorder.

Collaboration


Dive into the Oliver Ambrée's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Kathy Keyvani

University of Duisburg-Essen

View shared research outputs
Top Co-Authors

Avatar

Hemmo A. Drexhage

Erasmus University Rotterdam

View shared research outputs
Top Co-Authors

Avatar

Arne Herring

University of Duisburg-Essen

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Weiqi Zhang

University of Münster

View shared research outputs
Researchain Logo
Decentralizing Knowledge